MA
GWPH

MCF Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

MCF Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-34
Closed -$4K – 484
2019
Q3 		$4K Hold
34
– – ﹤0.01% 403
2019
Q2 		$6K Hold
34
– – ﹤0.01% 380
2019
Q1 		$6K Buy
+34
New +$5.06K ﹤0.01% 375

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MCF Advisors's GWPH Position: Q4 2019 in Review

MCF Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 34 shares — an estimated $4K sold.

MCF Advisors first reported a position in GWPH in Q1 2019 and held it in 3 quarters. The position peaked at $6K in Q2 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

  • MCF Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • MCF Advisors sold 34 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $4K.
  • MCF Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 3 quarters.
  • MCF Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $6K in Q2 2019.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on MCF Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.